SCHEMBL2643887

SCHEMBL2643887

Nc1cnc(-c2ccccc2O)cn1

nearest known ligand 0.66

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ FEN1 P39748 18/20 0.66
▸ ALOX5AP P20292 17/20 0.66
▸ KDM1A O60341 1/20 0.47
▸ IDO1 P14902 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15917145 0.81 FEN1 (1.00) FEN1ALOX5AP
SCHEMBL14988677 0.77 KDM1A (0.59) FEN1ALOX5APKDM1AIDO1
SCHEMBL28107573 0.77 FEN1 (0.66) FEN1ALOX5AP
SCHEMBL2030727 0.77 FEN1 (0.66) FEN1ALOX5APIDO1
SCHEMBL3010313 0.77 FEN1 (0.77) FEN1ALOX5AP
SCHEMBL15916606 0.75 ALOX5AP (0.78) FEN1ALOX5AP
SCHEMBL27761291 0.74 FEN1 (0.55) FEN1ALOX5APKDM1A
SCHEMBL20627407 0.74 FEN1 (0.57) FEN1ALOX5AP
SCHEMBL29518695 0.74 IDO1 (0.43) FEN1ALOX5APKDM1AIDO1
SCHEMBL10005680 0.74 ATR (0.49) FEN1ALOX5AP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107857342-A It is a kind of with the electrolyzing sewage pond of solar silicon plate and its method of work 徐州工程学院 2018-03-30 — — CN claimed
CN-107857342-A It is a kind of with the electrolyzing sewage pond of solar silicon plate and its method of work 徐州工程学院 2018-03-30 — — CN disclosed
EP-1572670-B1 5-SUBSTITUTED-PYRAZINE OR -PYRIDINE GLUCOKINASE ACTIVATORS HOFFMANN LA ROCHE (CH) 2007-08-22 — — EP disclosed
US-7132425-B2 5-substituted-six-membered heteroaromatic glucokinase activators HOFFMANN-LA ROCHE INC. (US) 2006-11-07 — — US disclosed
EP-1572670-A1 5-SUBSTITUTED-PYRAZINE OR -PYRIDINE GLUCOKINASE ACTIVATORS F. HOFFMANN-LA ROCHE AG (CH) 2005-09-14 — — EP disclosed
US-20040147748-A1 5-Substituted-six-membered heteroaromatic glucokinase activators CHEN SHAOQING (US) 2004-07-29 — — US disclosed
WO-2004052869-A1 5-SUBSTITUTED-PYRAZINE OR PYRIDINE GLUCOKINASE ACTIVATORS F. HOFFMANN-LA ROCHE AG (CH) 2004-06-24 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040147748-A1 5-Substituted-six-membered heteroaromatic glucokinase activators GCK, GCKR, GALK1 FEN1 4364/4885ALOX5AP 3219/4885KDM1A 2594/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback